Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Neck Tumors"'
Autor:
Yukihiro Takayasu, Nobuteru Kubo, Masato Shino, Osamu Nikkuni, Shota Ida, Atsushi Musha, Katsumasa Takahashi, Junko Hirato, Katsuyuki Shirai, Jun‐ichi Saitoh, Satoshi Yokoo, Kazuaki Chikamatsu, Tatsuya Ohno, Takashi Nakano, for the Working Group on Head and Neck Tumors
Publikováno v:
Cancer Medicine, Vol 8, Iss 17, Pp 7227-7235 (2019)
Abstract This study aimed to evaluate the efficacy of carbon‐ion radiotherapy in combination with chemotherapy using dacarbazine, nimustine, and vincristine (DAV therapy) in mucosal melanoma. Twenty‐one patients with clinically localized mucosal
Externí odkaz:
https://doaj.org/article/2b6a734a2c474461be926670ea000ca2
Autor:
Osamu Nikkuni, Nobuteru Kubo, Satoshi Yokoo, Masato Shino, Shota Ida, Katsuyuki Shirai, Neck Tumors, Tatsuya Ohno, Takuya Kaminuma, Hiro Sato, Naoko Okano, Masaru Ogawa, Jun-ichi Saitoh, Hidemasa Kawamura, Yukihiro Takayasu, Kazuaki Chikamatsu, Atsushi Musha
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:280-286
Objective Data on the long-term outcomes of carbon-ion radiotherapy for non-squamous cell carcinomas are rare. Gunma University has been utilizing carbon-ion radiotherapy as a treatment for head and neck cancer since 2010. This study aimed to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3efa9fcb3dc8b3ac303eee83551f6e
https://doi.org/10.1016/j.ajoms.2021.10.012
https://doi.org/10.1016/j.ajoms.2021.10.012
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katsumasa Takahashi, Junko Hirato, Tomoaki Tamaki, Neck Tumors, Minoru Toyoda, Hidemasa Kawamura, Satoshi Yokoo, Daijiro Kobayashi, Takeo Takahashi, Katsuyuki Shirai, Yukihiro Takayasu, Jun-ichi Saitoh, Takanori Abe, Tatsuya Ohno, Masato Shino, Kazuaki Chikamatsu, Tatsuya Nakano, Atsushi Musha
Publikováno v:
Cancer Science
To evaluate the efficacy and safety of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck, 35 patients were enrolled in this prospective study. The primary end-point was the 3-year local control rate, and the secondary end-p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad6382b8c54212da48b33b7b3fd51080
https://doi.org/10.1111/cas.13325
https://doi.org/10.1111/cas.13325
Autor:
Chatelet, Florian, Ferrand, François Régis, Atallah, Sarah, Thariat, Juliette, Mouawad, François, Fakhry, Nicolas, Malard, Olivier, Even, Caroline, de Monès, Erwan, Uro-Coste, Emmanuelle, Benzerdjeb, Nazim, Hans, Stéphane, Testelin, Sylvie, Mauvais, Olivier, Evrard, Diane, Bastit, Vianney, Salas, Sébastien, Espitalier, Florent, Classe, Marion, Digue, Laurence, Doré, Mélanie, Wong, Stéphanie, Dupin, Charles, Nguyen, France, Bettoni, Jeremie, Lapierre, Ariane, Colin, Emilien, Philouze, Pierre, Vergez, Sébastien, Baujat, Bertrand, Herman, Philippe, Verillaud, Benjamin, Constans, Jean-Marc, Coutte, Alexandre, Devauchelle, Bernard
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2023, 185, pp.11-27. ⟨10.1016/j.ejca.2023.02.020⟩
European Journal of Cancer, 2023, 185, pp.11-27. ⟨10.1016/j.ejca.2023.02.020⟩
International audience; Background: Acinic cell carcinomas (AciCCs) are malignant tumours of the salivary glands. The aim of this work was to analyse data from the national REFCOR multicenter cohort (i) to investigate the prognostic factors influenci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f5f70dfb687424dbf3ce99396e3d7e
https://doi.org/10.1016/j.ejca.2023.02.020
https://doi.org/10.1016/j.ejca.2023.02.020
Autor:
A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin, F.R. Ferrand, B. Baujat, N. Saroul, O. Casiraghi, S. Vergez, P. Herman, F. Janot, J. Thariat, B. Vérillaud, L. de Gabory, S. Albert, G. Andry, E. Babin, C. Bach, J.-M. Badet, C. Badoual, A.C. Baglin, A. Banal, B. Barry, E. Baudin, R.J. Bensadoun, C. Bertolus, J.-P. Bessède, D. Blanchard, C. Borel, A. Bozorg-Grayeli, R. Breheret, P. Breton, L. Brugel, G. Calais, E. Cassagnau, L. Castillo, P. Ceruse, F. Chabolle, D. Chevalier, J.C. Chobaut, O. Choussy, A. Cosmidis, A. Coste, V. Costes, L. Crampette, V. Darrouzet, P. Demez, P. Dessi, B. Devauchelle, L. Digue, G. Dolivet, F. Dubrulle, S. Duflo, X. Dufour, C. Even, S. Faivre, N. Fakhry, C. Ferron, F. Floret, R. Garrel, L. Geoffrois, L. Gilain, A. Giovanni, A. Girod, B. Guerrier, S. Hans, P. Hofman, M. Housset, R. Jankowski, F. Jegoux, M. Juliéron, M.-C. Kaminsky, F. Kolb, J. Lacau St Guily, L. Laccoureye, B. Lallemant, P. Lang, E. Lartigau, J.-P. Lavieille, M. Lefevre, X. Leroy, O. Malard, F. Massip, O. Mauvais, J.-C. Merol, J. Michel, T. Mom, S. Morinière, E. de Monès, G. Moulin, G. Noel, G. Poissonnet, J.-M. Prades, D. de Raucourt, E. Reyt, C. Righini, Y. Marie Robin, F. Rolland, B. Ruhin, N. Sarroul, P. Schultz, E. Serrano, O. Sterkers, V. Strunski, A. Sudaka, M. Tassart, S. Testelin, A. Timochenko, B. Toussaint, E. Uro Coste, G. Valette, T. Van den Abbeele, A. Varoquaux, F. Veillon, M. Wassef
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
European Journal of Cancer, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
European Journal of Cancer, Elsevier, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
European Journal of Cancer, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
International audience; BACKGROUND:Head and neck mucosal melanoma (HNMM) is aggressive and rare, with a poor prognosis because of its high metastatic potential. The two main subtypes are sinonasal (sinonasal mucosal melanoma [SNMM]) and oral cavity (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f75be81e09dd32c82cc3f2cd0b3c1f
https://hal.umontpellier.fr/hal-02548630
https://hal.umontpellier.fr/hal-02548630
Autor:
Ana Barat, Arij Ben Chaaben, François-Régis Ferrand, Aurore Gelin, Charles-Henry Gattolliat, Claire Gourzones, Fethi Guemira, Corinne Amiel, Joël Guigay, Anne-Sophie Jimenez-Pailhes, Philippe Lang, Jihène Klibi, Maryse Guerin, Véronique Schneider, Benjamin Verillaud, Philippe Busson
Publikováno v:
Virology Journal
Virology Journal, BioMed Central, 2013, 10 (1), pp.119. 〈10.1186/1743-422X-10-119〉
Virology Journal, 2013, 10 (1), pp.119. ⟨10.1186/1743-422X-10-119⟩
Virology Journal, BioMed Central, 2013, 10 (1), pp.119. ⟨10.1186/1743-422X-10-119⟩
Virology Journal, BioMed Central, 2013, 10 (1), pp.119. 〈10.1186/1743-422X-10-119〉
Virology Journal, 2013, 10 (1), pp.119. ⟨10.1186/1743-422X-10-119⟩
Virology Journal, BioMed Central, 2013, 10 (1), pp.119. ⟨10.1186/1743-422X-10-119⟩
Background Because latent Epstein Barr (EBV)-infection is a specific characteristic of malignant nasopharyngeal carcinoma (NPC), various molecules of viral origin are obvious candidate biomarkers in this disease. In a previous study, we could show in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f8adf2fae9c7ebbb9f3d1de64f7133
http://www.hal.inserm.fr/inserm-00835488/document
http://www.hal.inserm.fr/inserm-00835488/document
Autor:
Santos M; EORTC Quality of Life Group, Head and Neck Tumors, Brussels, Belgium; Radiation therapy Department, Brasília University, Brasília, DF, Brazil. Electronic address: marcosrxt@gmail.com., Oliveira E Silva LF; Radiation therapy Department, Brasília University, Brasília, DF, Brazil., Kohler HF; AC Camargo Cancer Center-São Paulo, SP, Brazil., Curioni O; Hospital Heliópolis, São Paulo, SP, Brazil; Prevent Sênior, São Paulo, SP, Brazil., Vilela R; Radiation therapy Department, Brasília University, Brasília, DF, Brazil., Fang M; Prevent Sênior, São Paulo, SP, Brazil., Lima CSP; Oncology Department, University of Campinas (Unicamp), Campinas, SP, Brazil., Gomes JP; Oncology Department, University of Campinas (Unicamp), Campinas, SP, Brazil., Chaves A; Head and Neck Cancer Research Group, Oncology Department, Universidade Federal de São João Del Rey, MG, Brazil., Resende B; Hospital Evangélico de Cachoeiro do Itapemirim, Cachoeiro do Itapemirim, ES, Brazil., Trindade K; Santa Casa de Fortaleza, Fortaleza, CE, Brazil., Collares M; Santa Casa de Bagé, Bagé, RS, Brazil., Obst F; Radiation therapy Department, Pontifícia Universidade Católica, Porto Alegre, RS, Brazil., Brollo J; Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil., Cavalieri R; Oncobeda, Centro Integrado de Oncologia, Campos, RJ, Brazil., Ferreira E; Radiation therapy Department, Brasília University, Brasília, DF, Brazil., Brust L; Hospital Bruno Born, Lajeado, RS, Brazil., Rabello D; Radiation therapy Department, Brasília University, Brasília, DF, Brazil., Domenge C; Société Franco-Brésilienne de Cancérologie, Nice, France., Kowalski LP; AC Camargo Cancer Center-São Paulo, SP, Brazil.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Feb 01; Vol. 121 (2), pp. 573.
Autor:
Maiorano BA; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: maiorano.brigida@hsr.it., Catalano M; Department of Health Sciences, University of Florence, Florence, Italy., Mercinelli C; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitana Pisana, Pisa, Italy., Roviello G; Department of Health Sciences, University of Florence, Florence, Italy., Maruzzo M; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto (IOV) - Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Chiellino S; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy., Sbrana A; Oncology Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Galli L; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitana Pisana, Pisa, Italy., Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Masini C; Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Naglieri E; Division of Medical Oncology, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Procopio G; Prostate Program, Genito-urinari Medical Oncology, IRCCS Foundation Istituto Nazionale Tumori, Milan, Italy., Merler S; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona & Verona University & Hospital Trust, Verona, Italy., Fratino L; Medical Oncology, Centro di Riferimento Oncologico di Aviano, National Cancer Institute, Aviano, Italy., Baldessari C; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Ricotta R; Medical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Sorarù M; UOC Oncologia, AULSS 6 Euganea, Ospedale di Camposampiero, Padova, Italy., Tudini M; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy., Prati V; Oncology Unit, Michele e Pietro Ferrero Hospital, Azienda Sanitaria Locale (ASL) CN 2, Verduno, Italy., Malgeri A; Department of Medical Oncology, Fondazione Policlinico Campus Bio-Medico, Roma, Italy., Atzori F; SSD Oncologia Medica, Azienda Sanitaria Locale (ASL) Sulcis, Cagliari, Italy., Napoli MD; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Caffo O; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Spada M; UOC Oncologia Medica, Istituto Fondazione G. Giglio, Cefalù, Italy., Morelli F; Medical Oncology Department, Casa Sollievo Della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy., Prati G; Department of Oncology, Advanced Technologies AUSL - IRCCS Reggio Emilia, Reggio Emilia, Italy., Nolè F; Medical OncologyDivision of Urogenital & Head & Neck Tumors, IEO, European Institute of Oncology IRCCS, Milano, Italy., Vignani F; Division of Medical Oncology, Ordine Mauriziano Hospital, Torino, Italy., Cavo A; Oncology Unit, Villa Scassi Hospital, Genova, Italy., Lipari H; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy., Puglisi S; Medical Oncology 2 Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Signori A; Department of Health Sciences, University of Genoa, Genoa, Italy., Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; Vita e Salute San Raffaele University, Milan, Italy., Banna GL; Portsmouth Hospitals University NHS Trust, Portsmouth, UK; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino of Genova, Genova, Italy., Buti S; Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy., Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2025 Feb; Vol. 23 (1), pp. 102267. Date of Electronic Publication: 2024 Nov 10.
Autor:
León X; Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, C/Mas Casanovas, 90, 08041, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.; Facultad de Medicina, UVIC, Universitat Central de Catalunya, Vic, Spain., Valero C; Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, C/Mas Casanovas, 90, 08041, Barcelona, Spain. cvalero@santpau.cat., Fuster G; Department of Biomedicine and Department of Biochemistry and Molecular Biomedicine, University of Barcelona (UB) and Institute of Biomedicine of the University of Barcelona (IBUB), Barcelona, Spain.; Biosciences Department, Sciences Technology and Engineering Faculty, Tissue Repair and Regeneration Group, UVIC, Vic, Spain., Bragado P; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain., Camacho M; Genomics of Complex Diseases, Research Institute Hospital Sant Pau, IIB Sant Pau, Barcelona, Spain., Avilés-Jurado FX; Head Neck Tumors Unit, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2025 Jan; Vol. 27 (1), pp. 160-165. Date of Electronic Publication: 2024 Jun 19.